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1. Introduction 
Progressive muscle weakness is the major symptom of patients with muscular dystrophy. 
The aims of the chapter are to introduce the strength decrease pattern and functional 
assessment, and to exam the advantages and disadvantages of these measurements applied 
to various types of muscular dystrophy. Three parts of the measurement for muscular 
dystrophy are included: the strength decrease pattern, the common general functional 
scales, and the disease specific scale.  
This chapter places emphasis on patients with more weakness in proximal than distal parts. 
The most common type of proximal muscular dystrophy is Duchenne muscular dystrophy 
(DMD). Due to rapid deterioration, DMD can be seen as a severe form of muscular 
dystrophy. Other types of proximal muscular dystrophies have a slower rate of disease 
progression compared to DMD, such as Beck muscular dystrophy (BMD), limb girdle 
muscular dystrophy (LGMD), facioscapulohumeral muscular dystrophy (FSHD) and others.  
2. Strength measurement 
Muscle strength can be assessed by many methods, such as manual muscle testing (MMT) and 
using the quantitative methods by instrument. Common instruments include the handheld 
dynamometer (HHD), and the isokinetic dynamometry or other fixation instruments.  
For MMT method, the Medical Research Council (MRC) Scale is the most often used system, 
with the procedures detecting the magnitude of strength by grading muscle strength from 0 
to 5. The MRC scale is an ordinal scale, with grades 0-5 also named as “Zero, Trace, Poor, 
Fair, Good, and Normal”. Grade 0 (Zero) cannot be palpated in muscle contraction. Grade 1 
(Trace) has some evidence of slight muscle contraction but the strength is too weak to move 
the joint. Grade 2 (Poor) strength can move the joint (full range of motion) when gravity is 
eliminated during the test. The Poor grade is sub-graded as Poor minus (2-), Poor, and Poor 
plus (2+). The 2- indicates strength able to move the joint but unable to complete the range 
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of motion. The 2+ indicates strength to complete the range of motion and also the ability to 
resist slight force made by the rater. Grade 3 (Fair) strength can be tested at the antigravity 
position. Similar to Poor grade, the Fair grade is sub-graded as Fair minus (3-: cannot 
complete the range of motion), Fair (3: can complete the range of motion), and Fair plus (3+: 
can against gravity with minimal resistance). Grade 4 (Good) completes the range of motion 
against gravity with moderate resistance, and Grade 5 (Normal) can resist with strong 
resistance. We recommend using the MMT method to measure the strength decrease pattern 
for patients with muscular dystrophy especially in clinical applications. The MMT grading 
system can clearly provide information as to whether patients can move their body in an 
antigravity position, and even if the strength is very weak, the strength can be discriminated 
by grade Poor, Trace or Zero. The weakness strength of patients with muscular dystrophy 
may be unable to be measured by some instrumentation, as most of these are designed to be 
measured in an antigravity position and the resistance is added during the measurement. 
The grading system is also graded (recorded) as different symbol methods. For example, the 
Kendall system ranked the grade from 0 to 10: it leaves the 0 as Zero, and 10 as Normal, and 
transforms the strength to a percentage, with a range from 0 to 100 %; the 100% being the 
grade of “Normal” strength. The percentages of Normal grade strength can be used for 
calculating the mean strength from many muscles. (Kendall et al., 1993) 
For isokinetic dynamometer or other fixation methods in strength measurement, complicated 
procedures are often not practicable due to the expense and time required to prepare the 
instruments. Although inconvenient, isokinetic dynamometry has been considered to be the 
gold standard for assessing dynamic muscle strength and provides much information of 
various muscle performance characteristics (Mark et al., 2004). The isokinetic strength has been 
studied in patients with mild or moderate strength impairment (Kilmer et al., 1994; Tiffreau et 
al., 2007). The patient with DMD with severe progressive muscle weakness highlights the 
method’s limitations for assessment of very weak strength (Bäckman, 1988). 
For HHD, it is a convenient, portable and inexpensive device for assessing isometric 
strength in a clinical setting. The rater handholds the device and presses it against the force 
that subjects exert with maximal effort. The make test and break test are two methods for 
HHD. In the make test, the rater resists the patient’s maximal isometric contraction, whereas 
in the break test the rater overcomes the force of the patient produced in eccentric 
contraction (Bohannon, 1988; Stratford & Balsor, 1994). Both methods have their advantage 
and disadvantages. To measure the weakness strength of patients with muscular dystrophy, 
we suggest using the make method. The HHD has been studied in DMD; the strength 
measured by a force transducer and the data presented in Newtons or kilograms has been 
seen as real compared to the MMT method where the strength record is in ratio-level 
parametric data (Scott & Mawson, 2006; Brussock et al., 1992; Stuberg & Metcalf, 1988) 
However, the main disadvantage of the HHD is the unsure reliability of some muscle 
strength on the tester when stabilizing the dynamometer (Bohannon, 1999). 
3. Strength decrease pattern of various types of muscular dystrophy 
3.1 Methods of strength measurement 
We previously measured the strength decrease pattern of some common types of muscular 
dystrophy, such as Duchenne muscular dystrophy (DMD), limb girdle muscular dystrophy 
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(LGMD) and facioscapulohumeral muscular dystrophy (FSHD) (Lue et al., 1992; Lue & 
Chen, 2000a; Lue & Chen, 2000b). Patients had been diagnosis by two qualified neurologists 
and followed up for at least two years. Before the strength measurement, they did not 
receive medication or a strengthening program for improving muscle strength.  
The manual muscle test was used by well trained physical therapists. Thirty-two muscle 
groups were examined on both sides; the muscle groups included neck and trunk muscles, 
and upper and lower extremities. The neck and trunk muscles included neck flexors/extensor 
and the trunk flexors/extensors. In the upper extremities, the shoulder (flexors, extensors, and 
abductors), elbow (flexors and extensors) and wrist (flexors and extensors) muscle strength 
were measured. In the lower extremities, the hip (flexors, extensors, and abductors), knee 
(flexors and extensors) and ankle (dorsi- and plantar-flexors) muscle strength were measured. 
To calculate the mean strength, we used Kendall’s percentage method (Kendall et al., 1993).  
3.2 Natural strength decrease pattern of patients with DMD 
DMD is a quick deterioration muscular dystrophy, with the strength decrease in a linear 
pattern positively correlated with age. For every year increment in age, the average strength 
decreases by about 3.9 percent of normal strength. About half of normal strength will be 
retained at the age of 12 years. The lower extremities are weaker than the upper extremities. 
The proximal parts are weaker than distal parts; the weakness of the elbow and wrist 
extensors is more dominant than that of the flexors. In the lower extremities, hip and knee 
extensors are weaker than hip and knee flexors. If the strengths of agonist and antagonist 
muscles of a joint are significantly different, the part of the stronger side becomes shorter 
and joint contracture easily develops. Therefore, in the upper extremities, elbow and wrist 
flexion contracture is easily found. Routine active or passive range of motion exercise for 
patients to maintain the full range of motion is a very important part of any rehabilitation 
program. Similar to the upper extremities, in the lower extremities, hip flexor contracture is 
commonly found in early stages of DMD; after the patients are unable to walk, the knee 
joints may develop severe flexion contracture as the joints are not routinely performing the 
(normal) range of motion exercises. At the end of life of a patient with DMD, the strength of 
finger flexors can manage some activities, even though at the age of twenty. Therefore, we 
recommend using computer games as finger exercises or a leisure activity for patients with 
DMD, and the keyboard may or may not need modification. 
3.3 Natural strength decrease pattern of patients with LGMD 
LGMD is also named limb girdle muscular dystrophy syndrome, which is combined with 
various types of limb girdle muscular dystrophy. Therefore, the strength decrease pattern 
has greater variation than other types of muscular dystrophy. The speed of muscle strength 
decrease will become slower than the onset after long disease duration. The strength 
decrease patterns do not fit well in a linear regression model (R2 only 0.074), and fit better in 
an inverse regression model (R2 equal to 0.154), with the equation as follows: mean muscle 
strength = 0.61+(0.63/disease duration). No significantly stronger strength in flexor than 
extensor muscles for extremities are found in patients with LGMD. The limitation of this 
study needs to be mentioned, as these patients with LGMD may or may not have only one 
type of LGMD. For more precise study in the future, the gene deficit should be confirmed 
and including the same type of LGMD for strength study is essential. 
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3.4 Natural strength decrease pattern of patients with FSHD 
Comparing the severity of the strength decrease, the strength decrease of patients with 
FSHD is the mildest compared to the strength decrease of patients with LGMD or DMD. The 
shoulder muscle strength is the weakest, followed by elbow muscle strength. The strengths 
of the trunk area and lower extremities are the best. A special pattern of the strength 
asymmetry is found in patients with FSHD, as the average right side muscle strength is 
weaker than the left side. Most of the subjects included in this study were right-handed. The 
dominant side may increase the use and lead to more prominence of strength decrease, 
therefore, in clinical applications for patients with FSHMD, too many strengthening 
programs or overload activity for the upper extremities may not suit such patients. The 
mechanism for asymmetry of strength found in patients with FSHD still requires further 
studies to be elucidated.  
4. Functional measurements 
4.1 The brooke and vignos scales 
The common functional scales to rate the grade of disease severity are the Brooke Scale and 
the Vignos Scale. Both scales were firstly designed for DMD, and nowadays have been used 
in many neuromuscular diseases. The Brooke scale was designed to assess the upper 
extremity function. The grades of the Brooke scale range from 1 to 6; 1 means that the 
subject can elevate their arms full range to the head with the arms straight; while 2 means 
that the shoulder strength is insufficient to elevate their arms and the subject needs to flex 
the elbow to elevate the arms; in grades 3 and 4, the subject is unable to elevate the 
shoulders but can raise hands to the mouth with or without weight respectively; grade 5 
refers to the subject being unable to raise hands to the mouth and only some hand 
movement exists, while grade 6 refers to no useful function of hands (Table 1). 
 
Grade Description 
1 Starting with arms at the sides, the patient can abduct the arms in a full circle 
until they touch above the head 
2 Can raise arms above head only by flexing the elbow (shortening the 
circumference of the movement) or using accessory muscles 
3 Cannot raise hands above head, but can raise an 8-oz glass of water to the 
mouth 
4 Can raise hands to the mouth, but cannot raise an 8-oz glass of water to the 
mouth 
5 Cannot raise hands to the mouth, but can use hands to hold a pen or pick up 
pennies from the table 
6 Cannot raise hands to the mouth and has no useful function of hands 
Table 1. Grading system for the Brooke scale. 
The Vignos scale was designed to assess the lower extremity function. The grades of the 
Vignos scale range from 1 to 10; 1 means that the subject can walk and climb stairs without 
assistance; 2 and 3 means that the strength is insufficient to walk upstairs without assistance 
as they need to use a rail for climbing stairs (grade 2: in a normal speed; grade 3: slowly); 
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grades 4 and 5 refer to subjects still having the ability to walk unassisted but unable to climb 
stairs (grade 4 also can rise from a chair but grade 5 cannot); grades 6 to 8 refer to patients 
using the long leg brace for walking or standing (grade 6: walk without assistance; grade 7: 
walk with assistance for balance; grade 8: cannot walk, only for standing); grade 9 refers to 
the subject being unable to stand, but can sit in a wheelchair; and the final grade 10 refers to 
the subject being confined to a bed (Table 2). 
 
Grade Description 
1 Walks and climbs stairs without assistance 
2 Walks and climbs stair with aid of railing 
3 Walks and climbs stairs slowly with aid of railing  
(over 25 seconds for eight standard steps) 
4 Walks unassisted and rises from chair but cannot climb stairs 
5 Walks unassisted but cannot rise from chair or climb stairs 
6 Walks only with assistance or walks independently with long leg braces 
7 Walks in long leg braces but requires assistance for balance 
8 Stands in long leg braces but unable to walk even with assistance 
9 Is in a wheelchair 
10 Is confined to a bed 
Table 2. Grading system for the Vignos scale. 
4.2 Timed tests 
Some studies also record the time needed for some activities as a functional testing for 
patients with muscular dystrophy. The raters measure the time need for a person to 
complete the activity. The example of these common activities are climbing some steps of 
stairs, walking a fixed distance, sitting to standing from a chair, rising from the floor, 
dressing a cloth and cutting a square. 
5. Advantages and disadvantage of the common functional scales of various 
types of muscular dystrophy 
The Brooke and Vignos scales are easy to rate the severity of the patients, but the study 
found some disadvantages (Lue et al., 2009). We assessed the acceptability of the Brooke and 
Vignos scales in patients with DMD, BMD, FSHMD, and LGMD from a multi-center study. 
The patients with DMD were classified as severely progressive group, while the others 
(BMD, FSHD, and LGMD) were classified as slowly progressive group.  
The results showed that the Brooke and Vignos scales were easy to assess, and it took a little 
time to complete the tests, and the patients did not feel uncomfortable. The Brooke scale is 
acceptable to grade arm function of the severely progressive group; the DMD, each grade of 
the Brooke scale is distributed with the acceptable percentage (ranging from 7.1% to 33.3%). 
However, it is insufficient to discriminate differing levels of severity of the slowly 
progressive group (BMD, FSHMD, and LGMD). No subject was graded at 4, and only one 
was graded at 6. The floor effect was large in all types of the slowly progressive group 
(ranging from 20.0% to 61.9%), especially high in BMD.  
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In the Vignos scale, using the long leg brace to grade the lower limb function may be a major 
problem for this scale. Grades 6 to 8 are items using long leg braces for walking or standing; 
these grades are inapplicable, because some cases did not use long leg braces for walking or 
standing. The floor effect of the Vignos scale was also large in BMD (23.8%) and in FSHD 
(50.0%). Among the slowly progressive muscular dystrophies, the function of patients with 
FSHD was the best; they had better leg function and were less influenced in their daily 
living activities than other types of slowly progressive muscular dystrophy. Using the two 
scales in combination with other measures (or instead, to use a complicated instrument for 
various types of muscular dystrophy) to calculate their function is suggested. 
6. The muscular dystrophy functional rating scale 
The Muscular Dystrophy Functional Rating Scale (MDFRS) is a disease specific scale 
designed for various muscular dystrophies. The MDFRS was developed by Lue et al. in 
2006. Four domains are included in MDFRS. It was developed in many stages: the 
preliminary pool of items, the admission of various types of muscular dystrophies and the 
reliability, validity and responsiveness studies (Lue et al. 2006). The results showed the 
MDFRS is a reliable and valid disease-specific measure of functional status for patients with 
muscular dystrophy. The internal consistency was excellent, with the value of the Cronbach’ 
alpha ranging from 0.84 to 0.97. The test-retest reliability and the inter-rater reliability were 
high (ICC=0.99) for all domains. The MDFRS demonstrated moderate to high correlation 
with a range of functional rating scales. The confirmatory factor analysis supported a four-
dimensional construct. The floor and ceiling effects were small and the responsiveness of 
various types of muscular dystrophies was well. 
The MDFRS combines four domains to rate mobility, basic activities of daily living, arm 
function and impairment. The number of items of each domain is 9, 6, 7 and 11 respectively 
(Table 3). The scale offers much important information of muscular dystrophy such as the 
mobility ability, dependence of daily living, the arm function, and many impairment 
conditions. The arm function part of the MDFRS effectively conquers the disadvantages of 
the Brooke scale (Lue et al. 2006; Lue 2010). 
Each item of MDFRS is scored on a 4-point scale (1-4), with 1 representing being unable to 
do the activity and is completely dependent; 2 needing assistance from another person, 3 is 
independent, without assistance from another person but movement or completion of an 
activity is slow, and 4 means no problem for the activity and can be done at normal speed. 
The impairment domain includes the items for measuring contractures and scoliosis, 
strengths, and respiratory function, and the scoring system was specially designed by the 
characteristics of the items.  
In the mobility domain, the 9 items included measuring the ability of stair climbing, outdoor 
mobility, indoor mobility, transfers from bed to chair, wheelchair manipulation, standing 
from sitting, sitting from lying, rolling and changing body position in bed. The items of stair 
climbing, outdoor and indoor mobility can effectively rate the function of the initial stage of 
the disease, and the ability of the sitting from lying, rolling and changing body position in 
bed is needed to examine the condition of the patients with terminal stages of the disease, 
such as the patients with DMD.  
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 Domains 
    
Mobility domain Basic ADL domain Arm function domain Impairment domain 
 
1 Stair climbing 1 Feeding 1 
Managing objects 
over head 
1 
Severity of upper 
limb joint 
contracture 
        
2 
Outdoor 
mobility 
2 Combing hair 2 Carrying objects 2 
Severity of lower 
limb joint 
contractures 
        
3 Indoor mobility 3 Brushing teeth 3 Cleaning table 3 
Number of 
contracted joints 
in the upper 
limbs 
        
4 
Transfers from 
bed to chair 
4 
Dressing 
upper/lower parts 
of body 
4 Writing 4 
Number of 
contracted joints 
in the lower 
limbs 
        
5 
Wheelchair 
manipulation 
5 Toileting 5 Turning books 5 
Severity of neck 
contracture 
        
6 
Standing from 
sitting 
6 Bathing 6 
Picking up small 
objects 
6 
Strength of the 
neck 
        
7 
Sitting from 
lying 
  7 
Managing objects 
over head 
7 
Strength of the 
trunk 
        
8 Rolling     8 Scoliosis 
        
9 
Changing body 
position in bed 
    9 Orthopnea 
        
      10 Sputum clearance 
        
      11 
Ventilator 
assisted 
        
Table 3. Domains and Items of the Muscular Dystrophy Functional Rating Scale. 
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In the basic activity daily living domain, the 6 items included measuring the ability of 
feeding, combing hair, brushing teeth, dressing upper/lower parts of body, toileting and 
bathing. The bathing activity is the most difficult item, and the feeding and combing hair 
items are easy activities for patients with muscular dystrophy. 
In the arm function domain, the 7 items included measuring the ability of managing objects 
overhead, carrying objects, clearing a table, writing, turning books, picking up small objects, 
and manipulating small objects. The items were designed to be more functional as needed 
for daily routine activities. The ability of managing objects over the head and carrying 
objects is useful to assess the better upper extremity function for patients with muscular 
dystrophy. 
The part of impairment section of the MDFRS offers simple measurement methods for 
measuring the condition of the contracture and scoliosis, weakness of the head and trunk 
muscles to provide head control and sitting balance, and the condition of the pulmonary 
function. In the impairment domain, the 11 items included measuring the problem of 
severity of upper and lower limb joint contracture, the number of contracted joints in the 
upper and lower limbs, the severity of neck contracture, strength of the neck, strength of the 
trunk, severity of the scoliosis, and three respiratory problems such as orthopnea, sputum 
clearance ability, and the need to use a ventilator. These impairment items are all important 
symptoms and signs of the various types of muscular dystrophy, and decreasing the 
complication of contracture is the most important issue for management of such patients. At 
the end stage of the disease, vital respiratory care needs to be added, and the 3 items of 
impairment domain of the MDFRS could offer the general condition of the pulmonary 
function. Therefore, the assessment from the impairment domain could offer a lot of useful 
information for clinicians and caregivers to easily know the condition of the patients and 
provide better care for them at different stages of the disease. 
The total scores of each domain sum up the scores of each item, therefore, the range of 
scores for 4 domains are 9-36 for the mobility domain, 6-24 for the basic activity of daily 
living domain, 7-28 for the arm domain, and 11-44 for the impairment domain respectively. 
The scores of each domain can be calculated as a percentage to represent the functional 
performance of a person compared to normal condition; the equation is as follows: (total 
scores-number of item) / full total scores and multiple 100. The % of mobility ability = (the 
sum of score from 9 item -9) / 36 *100; the % of basic activity of daily living ability = (the 
sum of score from 6 item -6) / 24 *100; the % of arm function ability = (the sum of score from 
7 item -7) / 28 *100; and the % of impairment condition = (the sum of score from 11 item -11) 
/ 44 *100. 
7. Conclusion 
In conclusion, various types of muscular dystrophy present differing speeds of disease 
progression with decreasing muscular strength in different patterns. Due to some 
disadvantages of the Brooke and Vignos grading scales applied to patients with muscular 
dystrophy, clinical application of these scales should be used with caution, especially in 
patients with slowly progressive muscular dystrophy. We suggest that the applications can 
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be used in combination with MDFRS, which is a multi-domain instrument, a valid and 
reliable scale, capable of evaluating the various levels of functional status of different types 
of muscular dystrophy. 
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